Details for New Drug Application (NDA): 021190
✉ Email this page to a colleague
The generic ingredient in BUSPAR is buspirone hydrochloride. There are nineteen drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the buspirone hydrochloride profile page.
Summary for 021190
Tradename: | BUSPAR |
Applicant: | Bristol Myers Squibb |
Ingredient: | buspirone hydrochloride |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 021190
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 20, 2000 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 20, 2000 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 20, 2000 | TE: | RLD: | Yes |
Expired US Patents for NDA 021190
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bristol Myers Squibb | BUSPAR | buspirone hydrochloride | CAPSULE;ORAL | 021190-004 | Dec 20, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Bristol Myers Squibb | BUSPAR | buspirone hydrochloride | CAPSULE;ORAL | 021190-001 | Dec 20, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Bristol Myers Squibb | BUSPAR | buspirone hydrochloride | CAPSULE;ORAL | 021190-003 | Dec 20, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Bristol Myers Squibb | BUSPAR | buspirone hydrochloride | CAPSULE;ORAL | 021190-002 | Dec 20, 2000 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription